Acadia Pharmaceuticals (ACAD) Current Leases (2011 - 2012)
Acadia Pharmaceuticals (ACAD) posted quarterly Current Leases of $3000.0 for Q3 2012, down 76.92% quarter-over-quarter from $13000.0 in Q2 2012.
Powered by 
Analysis
Acadia Pharmaceuticals (ACAD) Current Leases (2011 - 2012) Analysis & Trends
Acadia Pharmaceuticals' Current Leases history runs 2 years deep, the most recent figure standing at $3000.0 for Q3 2012.
- In Q3 2012, Current Leases changed N/A year-over-year to $3000.0; the TTM figure through Sep 2012 stood at $3000.0 (changed N/A YoY), while the FY2011 annual figure was $32000.0, changed N/A from the prior year.
- Current Leases for Q3 2012 stood at $3000.0, down from $13000.0 in the prior quarter.
- The five-year high for Current Leases was $32000.0 in Q4 2011, with the low at $3000.0 in Q3 2012.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 11.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 16.75 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 21.95 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 45.93 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Acadia Pharmaceuticals | 4.82 Bn | 3.86 Bn | 279.64 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2012 | 3,000.00 |
| Jun 30, 2012 | 13,000.00 |
| Dec 31, 2011 | 32,000.00 |